Wendall Wierenga
EVP, Research & Development, Neurocrine Biosciences.
Companies
- Crinetics PharmaceuticalsBoard member Jul 17, 2018 to now1
- CytokineticsBoard member Feb 10, 2011 to now2
- CONCERT PHARMACEUTICALS, INC.Board member Mar 17, 2014 to Jun 18, 20183
- Apricus BiosciencesBoard member Mar 11, 2014 to Jan 8, 20184
- Onyx PharmaceuticalsBoard member Dec 14, 2006 to Oct 3, 20135
- Neurocrine BiosciencesEVP, Research & Development Jan 23, 2006 to Jan 23, 20066
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cytokinetics CYTK32,345 shares7$2.0M at $62.76Jul 15, 2025
Crinetics Pharmaceuticals116,146 shares8Jun 11, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 15, 2025Granted 164 shares at $38.01 of Cytokinetics7
- Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals8
- May 14, 2025Granted 7,333 shares of Cytokinetics9
- Apr 21, 2025Sold 20,000 shares at $38.46 of Cytokinetics10
- Apr 21, 2025Exercised options 20,000 shares at $6.21 of Cytokinetics10
- Apr 15, 2025Granted 162 shares at $38.56 of Cytokinetics11
- Jan 2, 2025Granted 127 shares at $48.93 of Cytokinetics12
- Dec 16, 2024Sold 742 shares at $48.61 of Cytokinetics13
- Dec 16, 2024Exercised options 742 shares at $7.37 of Cytokinetics13
- Nov 25, 2024Sold 742 shares at $50.00 of Cytokinetics14
- Nov 25, 2024Exercised options 742 shares at $7.37 of Cytokinetics14
- Oct 28, 2024Sold 4,452 shares at $52.25 of Cytokinetics15
- Oct 28, 2024Exercised options 4,452 shares at $7.37 of Cytokinetics15
- Oct 1, 2024Granted 118 shares at $52.60 of Cytokinetics16
- Jul 1, 2024Granted 114 shares of Cytokinetics17
- Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals18
- May 15, 2024Granted 5,600 shares of Cytokinetics19
- Jan 2, 2024Granted 74 shares at $84.12 of Cytokinetics20
- Dec 27, 2023Sold 5,000 shares at $73.60 of Cytokinetics21
- Dec 27, 2023Exercised options 5,000 shares at $4.44 of Cytokinetics21
- Dec 27, 2023Sold 5,000 shares at $73.60 of Cytokinetics21
- Dec 27, 2023Exercised options 5,000 shares at $4.44 of Cytokinetics21
- Oct 2, 2023Granted 448 shares at $27.88 of Cytokinetics22
- Aug 21, 2023Sold 6,020 shares at $32.02 of Cytokinetics23
- Aug 21, 2023Exercised options 6,020 shares at $6.72 of Cytokinetics23
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARCytokinetics, Board member
- 3
- 4SEC EDGARApricus Biosciences, Board member
- 5SEC EDGAROnyx Pharmaceuticals, Board member
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed May 14, 2025
- 10SEC EDGARForm 4 filed Apr 21, 2025
- 11SEC EDGARForm 4 filed Apr 16, 2025
- 12SEC EDGARForm 4 filed Jan 6, 2025
- 13SEC EDGARForm 4 filed Dec 16, 2024
- 14SEC EDGARForm 4 filed Nov 26, 2024
- 15SEC EDGARForm 4 filed Oct 31, 2024
- 16SEC EDGARForm 4 filed Oct 3, 2024
- 17SEC EDGARForm 4 filed Jul 3, 2024
- 18SEC EDGARForm 4 filed Jun 11, 2024
- 19SEC EDGARForm 4 filed May 16, 2024
- 20SEC EDGARForm 4 filed Jan 3, 2024
- 21SEC EDGARForm 4 filed Dec 27, 2023
- 22SEC EDGARForm 4 filed Oct 3, 2023
- 23SEC EDGARForm 4 filed Aug 21, 2023